The Value of CT Features and Demographic Data in the Differential Diagnosis of Type 2 Papillary Renal Cell Carcinoma from Fat-poor Angiomyolipoma and Oncocytoma

Overview

Journal Abdom Radiol (NY)

Publisher Springer

Specialties Gastroenterology
Radiology

Date 2022 Sep 10

PMID 36085376

Authors

Cuiping Zhou

Xiaohua Ban

Lin Luo

Changzheng Shi

Affiliations

Soon will be listed here.

Abstract

Purposes: To determine the CT features and demographic data predictive of type 2 papillary renal cell carcinoma (PRCC) that can help distinguish this neoplasm from fat-poor angiomyolipoma (fpAML) and oncocytoma.

Methods: Fifty-four patients with type 2 PRCC, 48 with fpAML, and 47 with oncocytoma in the kidney from multiple centers were retrospectively reviewed. The demographic data and CT features of type 2 PRCC were analyzed and compared with those of fpAML and oncocytoma by univariate analysis and multiple logistic regression analysis to determine the predictive factors for differential diagnosis. Then, receiver operating characteristic (ROC) curve analysis was performed to further assess the logistic regression model and set the threshold level values of the numerical parameters.

Results: Older age (≥ 46.5 years), unenhanced lesion-to-renal cortex attenuation (RLRCA) < 1.21, corticomedullary ratio of lesion to renal cortex net enhancement (RLRCNE) < 0.32, and size ≥ 30.1 mm were independent predictors for distinguishing type 2 PRCC from fpAML (OR 14.155, 8.332, and 57.745, respectively, P < 0.05 for all). The area under the curve (AUC) of the multiple logistic regression model in the ROC curve analysis was 0.970. In the combined evaluation, the four independent predictors had a sensitivity and specificity of 0.896 and 0.889, respectively. A corticomedullary RLRCNE < 0.61, irregular shape, and male sex were independent predictors for the differential diagnosis of type 2 PRCC from oncocytoma (OR 15.714, 12.158, and 6.175, respectively, P < 0.05 for all). In the combined evaluation, the three independent predictors had a sensitivity and specificity of 0.889 and 0.979, respectively. The AUC of the multiple logistic regression model in the ROC curve analysis was 0.964.

Conclusion: The combined application of CT features and demographic data had good ability in distinguishing type 2 PRCC from fpAML and oncocytoma, respectively.

References

Warren A, Harrison D . WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies. World J Urol. 2018; 36(12):1913-1926. PMC: 6280811. DOI: 10.1007/s00345-018-2447-8. View

Young J, Margolis D, Sauk S, Pantuck A, Sayre J, Raman S . Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 2013; 267(2):444-53. DOI: 10.1148/radiol.13112617. View

Kim S, Kim C, Kim M, Cho J, Cho S . Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT. AJR Am J Roentgenol. 2015; 206(1):W21-8. DOI: 10.2214/AJR.15.14666. View

Lee-Felker S, Felker E, Tan N, Margolis D, Young J, Sayre J . Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. AJR Am J Roentgenol. 2014; 203(5):W516-24. DOI: 10.2214/AJR.14.12460. View

Bird V, Kanagarajah P, Morillo G, Caruso D, Ayyathurai R, Leveillee R . Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography. World J Urol. 2010; 29(6):787-92. DOI: 10.1007/s00345-010-0586-7. View

Pierorazio P, Hyams E, Tsai S, Feng Z, Trock B, Mullins J . Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. Urology. 2013; 81(6):1265-71. PMC: 4648275. DOI: 10.1016/j.urology.2012.12.049. View

Sasaguri K, Takahashi N, Gomez-Cardona D, Leng S, Schmit G, Carter R . Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT. AJR Am J Roentgenol. 2015; 205(5):999-1007. DOI: 10.2214/AJR.14.13966. View

Moch H, Cubilla A, Humphrey P, Reuter V, Ulbright T . The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2016; 70(1):93-105. DOI: 10.1016/j.eururo.2016.02.029. View

Li C, Lu Q, Huang B, Wang P, Wang W . Routine or enhanced imaging to differentiate between type 1 and type 2 papillary renal cell carcinoma. Clin Radiol. 2020; 76(2):135-142. DOI: 10.1016/j.crad.2020.09.020. View

10.

Silverman S, Israel G, Herts B, Richie J . Management of the incidental renal mass. Radiology. 2008; 249(1):16-31. DOI: 10.1148/radiol.2491070783. View

11.

Silverman S, Mortele K, Tuncali K, Jinzaki M, Cibas E . Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation. Radiographics. 2007; 27(4):1131-43. DOI: 10.1148/rg.274065147. View

12.

Park B . Renal Angiomyolipoma Based on New Classification: How to Differentiate It From Renal Cell Carcinoma. AJR Am J Roentgenol. 2019; 212(3):582-588. DOI: 10.2214/AJR.18.20408. View

13.

Kim J, Cho J, Moon K, Lee H, Kim S . Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma. Radiology. 2009; 252(2):441-8. DOI: 10.1148/radiol.2522081180. View

14.

Yamada T, Endo M, Tsuboi M, Matsuhashi T, Takase K, Higano S . Differentiation of pathologic subtypes of papillary renal cell carcinoma on CT. AJR Am J Roentgenol. 2008; 191(5):1559-63. DOI: 10.2214/AJR.07.3181. View

15.

Egbert N, Caoili E, Cohan R, Davenport M, Francis I, Kunju L . Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR Am J Roentgenol. 2013; 201(2):347-55. DOI: 10.2214/AJR.12.9451. View

16.

Yang L, Li X, Hu Y, Zhang M, Yao J, Song B . Multidetector CT Characteristics of Fumarate Hydratase-Deficient Renal Cell Carcinoma and Papillary Type II Renal Cell Carcinoma. Korean J Radiol. 2021; 22(12):1996-2005. PMC: 8628156. DOI: 10.3348/kjr.2021.0212. View

17.

Jeong C, Park B, Park J, Kim C . Unenhanced CT and MRI Parameters That Can Be Used to Reliably Predict Fat-Invisible Angiomyolipoma. AJR Am J Roentgenol. 2016; 206(2):340-7. DOI: 10.2214/AJR.15.15086. View

18.

Lim R, Flood T, McInnes M, Lavallee L, Schieda N . Renal angiomyolipoma without visible fat: Can we make the diagnosis using CT and MRI?. Eur Radiol. 2017; 28(2):542-553. DOI: 10.1007/s00330-017-4988-4. View

19.

Ishigami K, Jones A, Dahmoush L, Leite L, Pakalniskis M, Barloon T . Imaging spectrum of renal oncocytomas: a pictorial review with pathologic correlation. Insights Imaging. 2014; 6(1):53-64. PMC: 4330236. DOI: 10.1007/s13244-014-0373-x. View